Suppr超能文献

消除脊髓灰质炎:印度从高度流行到无脊髓灰质炎状态的历程。

Eradicating poliomyelitis: India's journey from hyperendemic to polio-free status.

机构信息

Christian Medical College, Vellore, Tamil Nadu, India.

出版信息

Indian J Med Res. 2013 May;137(5):881-94.

Abstract

India's success in eliminating wild polioviruses (WPVs) has been acclaimed globally. Since the last case on January 13, 2011 success has been sustained for two years. By early 2014 India could be certified free of WPV transmission, if no indigenous transmission occurs, the chances of which is considered zero. Until early 1990s India was hyperendemic for polio, with an average of 500 to 1000 children getting paralysed daily. In spite of introducing trivalent oral poliovirus vaccine (tOPV) in the Expanded Programme on Immunization (EPI) in 1979, the burden of polio did not fall below that of the pre-EPI era for a decade. One of the main reasons was the low vaccine efficacy (VE) of tOPV against WPV types 1 and 3. The VE of tOPV was highest for type 2 and WPV type 2 was eliminated in 1999 itself as the average per-capita vaccine coverage reached 6. The VE against types 1 and 3 was the lowest in Uttar Pradesh and Bihar, where the force of transmission of WPVs was maximum on account of the highest infant-population density. Transmission was finally interrupted with sustained and extraordinary efforts. During the years since 2004 annual pulse polio vaccination campaigns were conducted 10 times each year, virtually every child was tracked and vaccinated - including in all transit points and transport vehicles, monovalent OPV types 1 and 3 were licensed and applied in titrated campaigns according to WPV epidemiology and bivalent OPV (bOPV, with both types 1 and 3) was developed and judiciously deployed. Elimination of WPVs with OPV is only phase 1 of polio eradication. India is poised to progress to phase 2, with introduction of inactivated poliovirus vaccine (IPV), switch from tOPV to bOPV and final elimination of all vaccine-related and vaccine-derived polioviruses. True polio eradication demands zero incidence of poliovirus infection, wild and vaccine.

摘要

印度成功消除野生脊灰病毒(WPV)在全球广受赞誉。自 2011 年 1 月 13 日最后一例病例以来,已持续两年无病例发生。如果不发生本土传播,到 2014 年初,印度就有可能获得 WPV 传播消除认证,而这种可能性被认为是零。直到 20 世纪 90 年代初,印度脊灰炎仍呈地方性流行,每天平均有 500 到 1000 名儿童瘫痪。尽管 1979 年在扩大免疫规划(EPI)中引入了三价口服脊灰炎疫苗(tOPV),但脊灰炎的负担在十年内并未低于 EPI 前时代。主要原因之一是 tOPV 对 WPV 1 型和 3 型的疫苗效力(VE)较低。tOPV 对 2 型的 VE 最高,WPV 2 型于 1999 年自行消除,因为人均疫苗覆盖率达到 6 。在北方邦和比哈尔邦,tOPV 对 1 型和 3 型的 VE 最低,WPV 的传播力度最大,因为婴儿人口密度最高。最终通过持续和非凡的努力中断了传播。自 2004 年以来,每年进行 10 次年度脉冲脊灰炎疫苗接种运动,几乎每个儿童都被追踪和接种疫苗——包括在所有过境点和运输车辆中,单价 OPV 1 型和 3 型根据 WPV 流行病学和双价 OPV(包含 1 型和 3 型)获得许可并进行滴定疫苗接种运动。使用 OPV 消除 WPV 只是脊灰炎根除的第一阶段。印度准备进入第二阶段,引入灭活脊灰炎疫苗(IPV),从 tOPV 切换到 bOPV,并最终消除所有疫苗相关和疫苗衍生的脊灰炎病毒。真正的脊灰炎根除需要零脊灰炎病毒感染,野生和疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ce1/3734678/33abc1bb612b/IJMR-137-881-g004.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验